EpiSkin Biotech License helps China to Advance Cosmetics without Animal Testing
Owner/Developer: Human Society International (HSI)
|Country:||United States of America|
Chinese authorities have granted a license for Shanghai EpiSkin Biotechnology Ltd to market its reconstructed human skin model. The development is hailed by Humane Society International’s China team as an important step towards enabling domestic cosmetics companies to replace animal tests with modern in vitro methods, and in so doing, take advantage of the very latest research technologies in product safety. Since China’s Food and Drug Administration introduced regulatory reforms in July, Chinese companies producing ordinary cosmetics no longer need to test finished products on animals, allowing for a substantial reduction in animal testing. The next step will be to increase the availability, uptake and acceptance of new in vitro technologies, and the licensing of EpiSkin marks an important step towards that goal.
|Channel:||Website - Social media|
|Audience:||Scientists - Policy-makers - Regulators - Industry - Researchers - Students - General public - Educators|
|User access:||Open access|
|Updating frequency:||October 6 - 2014|
|Relevance:||Replacement - Reduction|
|Purpose:||Documentation and information|
|Technology/Tools:||Alternative test methods (in vitro)|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!Please contact us by email if you have any questions.